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Helicobacter pylori (H. pylori) infection is closely related to various gastroduodenal
diseases. Virulence factors and bacterial load of H. pylori are associated with clinical
outcomes, and drug-resistance severely impacts the clinical efficacy of eradication
treatment. Existing detection methods are low-throughput, time-consuming and labor
intensive. Therefore, a rapid and high-throughput method is needed for clinical
diagnosis, treatment, and monitoring for H. pylori. High-throughput Multiplex Genetic
Detection System (HMGS) assay was established to simultaneously detect and analyze
a set of genes for H. pylori identification, quantification, virulence, and drug resistance
by optimizing the singlet-PCR and multiple primers assay. Twenty-one pairs of chimeric
primers consisted of conserved and specific gene sequences of H. pylori tagged with
universal sequence at the 5′ end were designed. Singlet-PCR assay and multiple
primers assay were developed to optimize the HMGS. The specificity of HMGS assay
was evaluated using standard H. pylori strains and bacterial controls. Six clinical isolates
with known genetic background of target genes were detected to assess the accuracy
of HMGS assay. Artificial mixed pathogen DNA templates were used to evaluate the
ability to distinguish mixed infections using HMGS assay. Furthermore, gastric biopsy
specimens with corresponding isolated strains were used to assess the capability of
HMGS assay in detecting biopsy specimens directly. HMGS assay was specific for
H. pylori identification. HMGS assay for H. pylori target genes detection were completely
consistent with the corresponding genetic background. Mixed infection with different
drug-resistant isolates of H. pylori could be distinguished by HMGS assay. HMGS assay
could efficiently diagnose H. pylori infection in gastric biopsy specimens directly. HMGS
assay is a rapid and high throughput method for the simultaneous identification and
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quantification of H. pylori, analysis of virulence and drug resistance in both isolated
strains and biopsy specimens. It could also be used to distinguish the mixed infection
with different resistant genotype strains. Furthermore, HMGS could detect H. pylori
infection in gastric biopsy specimens directly.
Keywords: Helicobacter pylori, high-throughput multiplex genetic detection system, identification, quantification,
virulence, resistance genes, mixed infection
INTRODUCTION
Helicobacter pylori (H. pylori), a micro-aerobic Gram-negative
bacteria, is closely associated with a variety of gastroduodenal
diseases, such as chronic superficial gastritis (CSG), chronic
atrophic gastritis (CAG), peptic ulcer diseases (PUD), and gastric
carcinoma (GC) (Venerito et al., 2016). More than half of the
adult population worldwide was infected by this pathogen and
the most serious incidence of infection was observed in East
Asia (de Martel et al., 2013). The analysis of different virulence,
gene-mutation related resistance and the bacterial load have been
revealed to be very important for effective clinical diagnosis,
treatment, and monitoring of H. pylori infection (Kusters et al.,
2006; Proença-Modena et al., 2009; Yamaoka, 2010).
Currently, various detection methods are available in clinical
practice, such as culture, histopathology, urea breath test (UBT),
rapid urease test (RUT), serology, and PCR, but each has
some disadvantages (Wang et al., 2015). To date, no single
method incorporates simultaneous analysis of strain-specific
features including identification, virulence characteristics,
drug-resistance, quantification, and evaluation of multi-strain
infections (Shukla et al., 2011). Thus, a rapid, accurate, and
high-content quantitative assay is required to directly assist
clinical diagnosis in tissue and improve the effectiveness of
diagnosis and antibiotic treatment.
Previously, our team has developed a genetic analysis method
using 16S rRNA and ureC for H. pylori identification and
quantification (Zhou et al., 2015). Here, we further explored and
developed a new multiple genes detection assay. In this study,
total 21 pairs of chimeric gene specific primers were designed
to establish a high-throughput multiple genetic detection system
(HMGS) for simultaneous bacterial diagnosis and identification
of virulence and resistance genes. The specificity of HMGS assay
was assessed using the standard H. pylori strains and bacterial
controls. Six clinical isolates with known genetic background of
target genes were detected to assess the accuracy of HMGS assay.
Artificially mixed DNA from different wild type and mutant
resistant isolates of H. pylori was used to evaluate the ability
to distinguish mixed infections. Furthermore, gastric biopsy
specimens with the corresponding isolated strains were used
to evaluate the capacity of HMGS assay in detecting biopsy
specimens directly.
MATERIALS AND METHODS
Ethics Statement
The study has been approved by Ethics Committee for human
studies of Huadong Hospital. The Ethics Approval Number:
[2013]-077.
Bacterial Strains and Clinical Specimens
The standard strains H. pylori ATCC43504, Escherichia coli
(E. coli) ATCC8739, Pseudomonas aeruginosa (P. aeruginosa)
ATCC35218, and Acinetobacter baumannii (A. baumannii)
ATCC19606 were purchased from Shanghai Municipal Center
for Disease Control & Prevention. Six clinical strains of
H. pylori with known genetic background and Campylobacter
jejuni (C. jejuni), Klebsiellar pneumonia (K. pneumonia),
Stenotrophomonas maltophilia (S. maltophilia) were isolated and
confirmed by their specific and conserved species genes. Two
clinical antrum tissue specimens were obtained from patients
who were diagnosed as H. pylori positive by C14 expiration test
and one uninfected antrum tissue from a healthy control in the
Huadong Hospital, Shanghai, China.
Culture and DNA extraction
Each antrum biopsy specimen was placed in 0.9% sterile saline
solution kept at 4◦C and sent to the microbiology laboratory
within 4 h. The biopsy specimens were homogenized using
TissueLyser (Jingxin Co., Ltd., Shanghai, China) and plated
on Columbia agar (OXOID Microbiology Products, Thermo
Fisher Scientific Inc., Waltharm, MA, USA) supplemented with
medium containing 8% sterile defibrinated sheep blood (Shunwei
Biotech Co., Ltd., Shanghai, China) and 0.5% selective antibiotics
(Sigma−Aldrich, USA) supplement. The cultures were kept
under microaerophilic conditions (5%O2, 10%CO2, 85%N2)
at 35◦C for 3−7 days. The isolates were frozen in glycerin
broth at −80◦C and the remained homogenated specimens
were kept in −80◦C for DNA extraction. Total DNA from
the standard strains, clinical isolates and H. pylori positive
biopsy specimens was extracted with a bacterial genomic DNA
extraction kit (Tiangen Biotech Co., Ltd., Beijing, China)
following the manufacturer’s instruction. The extracts were eluted
with 100 µL of DNase/RNase-free H2O (ddH2O). Concentration
of each extract was determined using a ThermoNano drop 2000
spectrophotometer (Thermo Fisher Scientific Inc., Waltharm,
MA, USA). The extracts were stored at −20◦C for further
analysis.
Primer Design
The primer set for HMGS assay consisted of 21 pairs of
chimeric primers, including identification gene 16S rRNA, 10
main virulence-associated genotypes cagA, vacA s1, vacA s2,
vacA m1, vacA m2, iceA1, iceA2, luxS, dupA, and oipA, four
drug resistance genes 23S rRNA (A2143G), rdxA (C148T),
gyrA(C261A/G), and pbp1A (A1777G), quantification gene of
ureC, and human tissue internal control beta-globin gene which
induced to normalize the specific gene expression. In addition,
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it also has one pair of universal primers. All chimeric primers
consisted of a gene-specific sequence tagged with a universal
sequence at the 5′ end to ensure the specific and equivalent
amplification. The forward universal primers were Cy5-labeled at
the 5′ end of the sequence. Hundreds of sequences for each target
from different region of the world, especially for those from Asia
were downloaded from the National Center of Biotechnology
Information (NCBI) and analyzed using Vector NTI to identify
the homolog regions. The primers were designed in highly
conserved regions using DNA star software (DNASTAR Inc.,
Madison, WI, USA) and Primer Premier 5.0 software (Premier
Biosoft International, Palo Alto, CA, USA). The specificity of
each single pair of primers was verified by conventional PCR
and sequencing. These gene-specific primers were designed and
optimized following several main principles: homogeneity, the
length of amplification product is 150−350 bp, at least three bases
difference between each amplicon, no significant dimers between
different primers, and no non-specific products by each pair of
gene-specific primers (Robertson and Walsh-Weller, 1998; Bruce,
2003). The primer sequences (Sunny Biotech Co., Ltd), the size
of the resulting amplicons, and their target genes were listed in
Table 1.
Singlet-PCR Assay
The singlet-PCR assay was conducted using DNA templates
verified by sequencing to evaluate the specificity of each pair of
pathogen-specific primers and to ascertain the actual fragment
size of each amplicon. The singlet-PCR assay was developed as
follows: The singlet-PCR assay contained 0.5 µL of DNA, 12.5 µL
of 2× buffer (Ex Taq polymerase, Mg2+, dNTP), 20 µM each of
the forward universal primer and reverse universal primer, and
1 µM each of the forward chimeric primer and reverse chimeric
primer. ddH2O was added to the PCR reaction to a final volume
of 25 µL. The PCR mixture was incubated at 95◦C for 5 min,
followed by two steps with different annealing temperatures: step
one, 12 PCR cycles of 30 s at 95◦C, 30 s at 60◦C, and 25 s at
72◦C; step two, 20 cycles at 95◦C for 30 s, 50◦C for 30 s, and
72◦C for 25 s; 5 min at 72◦C, before then being held at 4◦C
in a thermal cycler. After amplification, 1 µL of PCR product
that was diluted 10-fold was added to a 38.75 µL of specimens
loading solution, along with 0.25 µL of DNA size standard-400
(GenomeLab GeXP Start Kit; Beckman Coulter, USA). Finally,
a drop of mineral oil was added after blending. The GeXP
Genetic Analysis System (Beckman Coulter, USA) was then used
to analyze PCR products based on size separation using high-
resolution capillary gel electrophoresis. The peak height for each
PCR products was reported in the electropherogram and the
reaction was considered positive when the dye signal was greater
than 2,000 relative fluorescence units (rfu). ddH2O was used as a
negative control throughout the assay.
Establishment and Optimization of
HMGS
The multiple primers and reaction factors were further optimized
in one HMGS assay reaction. The multiplex quantitative PCR
was performed in a mixture containing MgCl2 solution, PCR
buffer, forward universal primers, reverse universal primers,
Taq polymerase, DNA template, and ddH2O. In details, the
reaction system was optimized as follows: All primers were added
to the reaction system with the same concentration and the
volume. After amplification, PCR products were prepared for
fragment analysis using GeXP Genetic Analysis System following
manufacture suggested protocols. One microliter of PCR product
was added to 30 µL of specimens loading solution along with
0.5 µL of DNA Size Standard 400 (AB Sciex, Inc., USA). The
mixture was added to a 96-well plate and was loaded onto a
GeXP Genetic Analysis System for capillary electrophoresis and
fragment separation. The peaks were initially analyzed based
on the sizes of the appropriate amplified products. The peak
height for each gene was reported in the electropherogram
and the dye signal intensity was measured by fluorescence
spectrophotometry in rfu (relative fluorescence unit). Then,
the concentrations of primers were adjusted to optimize signal
intensity for each target to be detected from 2,000 to 175,000 rfu.
If a signal peak was too high, the corresponding concentration
would be reduced until the peak intensity was moderate. If
a signal peak was too low or not detectable, the primer
concentration would be increased to enhance the signal intensity.
Additionally, the annealing temperature was optimized through
temperature gradient descent method (chimeric primers from 50
to 65◦C). Meanwhile, other factors of reaction conditions were
also optimized. The main optimized principle was to keep all
amplicons with similar amplification efficiency and presenting
the gene-specific target amplicon without cross-amplification.
Here, the ratio and concentration of primers were critical.
Meanwhile, other parameters of the reaction conditions such as
Tm value, reaction time and temperature were also important and
were systematically optimized. HMGS protocols referred to the
instruction of GeXP and previously reported paper (Zhou et al.,
2015).
Artificial Mixture
To mimic clinical phenomenon in which patients infected
different drug-resistant types of H. pylori simultaneously, four
pairs of isolated strains from biopsy specimens with known
genetic background, with mutation sites in 23S rRNA (A2143G),
rdxA (C148T), gyrA (C261A/G), and pbp1A (A1777G) were
chosen, and DNA from the wild type and mutant resistant
strains were artificially mixed together in equal concentrations
in HMGS assay. In addition, DNA extracts from clarithromycin
resistant isolated strain with mutation site in 23S rRNA (23S
rRNA_G) and from the wild type strain (23S rRNA_A) were
chosen to mix together using following template ratio: 1:8, 1:4,
1:2,1:1, 2:1, 4:1, and 8:1. HMGS assay was performed using the
mixed DNA.
Specificity, Sensitivity, and Accuracy of
HMGS Assay
To determine if optimized HMGS maintained high specificity for
H. pylori detection, HMGS assay readout of a standard H. pylori
stain (ATCC43504), ddH2O, and six control bacterial species
were tested in HMGS platform. Our control bacterial species
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FIGURE 1 | Singlet-PCR assay. The X-axis indicates the actual PCR product size, and the Y-axis indicates the dye signal. (A−T) Showed the results of the
amplification of genes, 16S rRNA, ureC, beta-globin, 23S rRNA_G, 23S rRNA_A, gyrA_G, gyrA_C, pbp1A gyrA_A, pbp1A gyrA_G, rdxA_T„ rdxA_C,oipA, dupA,
vacA m1, vacA m2, cagA, iceA1,iceA2, luxS, and vacA s1, respectively. Note that all gene targets were specifically amplified without nonspecific amplification by
singlet-PCR assay.
included: E. coli, P. aeruginosa, A. baumannii, S. maltophilia, K.
pneumoniae, as well as C. jejuni which has very similar growth
characteristics with H. pylori. To further confirm the specificity of
HMGS in complicated environment, we have mixed six control
bacterial species C. jejuni, E. coli, P. aeruginosa, A. baumannii,
S. maltophilia, and K. pneumoniae DNA (0.8 ng/µL of each
bacterial specie) with and without H. pylori DNA (0.4 ng/µL
of each bacterial specie) in PBS and then detected by HMGS
assay. The sensitivity of 21 primer pairs HMGS was conducted
by eight serial double dilutions of H. pylori DNA in PBS from the
concentration of 0.4 ng/µL to 3.125 × 10−3 ng/µL The HMGS
limit of detection was set by the criteria that the all H. pylori
specific signals would read above 2,000 rfu. Total six clinical
isolates with known genetic background of target genes verified
by Sanger sequencing and three antrum biopsy specimens (two
cases from the patients with H. pylori infection and one from
uninfected healthy control) were used to verify the accuracy of
HMGS.
Statistical Analysis
Statistical analysis of the linear correlation between the peak areas
and the template ratios of wild type and mutant drug resistant
isolates was carried out using SPSS version 17.0 software.
RESULTS
Individual Primers Selected for HMGS
Were Verified by Singlet-PCR Assay
The amplicon sizes for the target genes were as follows
(Figures 1A–T): identification gene16S rRNA: 147 bp;
quantification gene ureC: 138 bp; internal control gene
beta-globin: 199 bp; 10 important virulence genes cagA: 210 bp,
dupA: 187 bp, luxS: 242 bp, vacA s1: 299 bp, oipA: 317 bp,
vacA m1: 282 bp, vacA m2: 166bp, iceA1: 234 bp, and iceA2:
171bp/277 bp; four main resistance genes 23S rRNA(A2143G):
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175 bp/180 bp, rdxA(C148T): 253 bp/258 bp, pbp1A(A1777G):
154 bp/159 bp, and gyrA(C261A/G):306 bp/311 bp, respectively.
The result showed that all target genes were specifically amplified
without unintended products by their corresponding primers.
The Optimization of HMGS Conditions
Allowed for Efficient Use of Multiplex
Assay with High-Resolution Using
Isolates
The intensity of amplification signals for different targets varied
up to 100-fold when all primers were used at the same
concentration (Figure 2A). Therefore, the primer concentrations
for genes with saturated peaks, such as 16S rRNA and ureC, were
FIGURE 2 | The optimization of HMGS assay for H. pylori detection.
(A) The HMGS assay result showed specific gene from left to right was as
follow: ureC, 16S rRNA, vacA m2, 23S rRNA_A, beta-globin, cagA, luxS,
vacA s1, and oipA. (B) The targets genes from left to right are as follow: ureC,
16S rRNA, pbp1A, vacA m2, 23S rRNA_A, iceA2, beta-globin, cagA, luxS,
rdxA_C, vacA s1, gyrA_C, and oipA. Note that the specific genes pbp1A,
iceA2, and gyrA_C showed up and all the intensity of amplification signals for
target genes moderated to the middle range after optimization.
reduced to reach a moderate signal levels. On the other hand,
the primer concentrations for genes with very low peaks, such
as dupA, gyrA, and iceA1, were increased two- to threefold to
significantly enhance the signal levels. The overall signal intensity
for all targets was moderate to the middle range in HMGS assay
after optimization (Figure 2B).
HMGS Assay is Specific for H. pylori
Identification
The H. pylori standard strain ATCC43504 showed specific
amplification signals of H. pylori identification genes 16S rRNA
and ureC (Figure 3A), while other six control bacterial species
including C. jejuni, E. coli, P. aeruginosa, A. baumannii, S.
maltophilia, K. pneumoniae, and ddH2O did not produce
any signals that would indicate non-specific amplification
(Figures 3B–F). Furthermore, the control bacteria mix did not
display any H. pylori specific signals, while the control mix with
H. pylori showed all the specific signals (Figures 3H,I). The above
results demonstrated that the newly established and optimized
HMGS assay was highly specific for H. pylori identification. The
limit of sensitivity for HMGS simultaneous detection of all genes
using 21 primer pairs was 6.25 × 10−3 ng/µL while over 80% of
genes were still above the detection limit at 3.125 × 10−3 ng/µL
dilution of H. pylori DNA diluted in PBS.
HMGS Can Simultaneously Detect
Virulence and Drug Resistance Genes of
H. pylori
Six clinical isolates with known genetic background of target
genes were used to evaluate the accuracy of HMGS assay.
All the specific amplification signals were observed including
identification gene 16S rRNA, quantification gene ureC, internal
control beta-globin, 10 main virulence-associated genes cagA,
vacA s1, vacA s2, vacA m1, vacA m2, iceA1, iceA2, luxS,
dupA, and oipA, and four drug resistance genes pbp1A, gyrA,
23SrRNA, rdxA (Figure 4). These results demonstrated that
the optimized HMGS assay for target genes of H. pylori
were completely consistent with the corresponding genetic
background.
HMGS Assay Allowed for Detecting
Mixed Infection with Drug Resistant
Mutant and Wild Type Isolates in a Wide
Range of Proportions
The specific and distinct amplification signals for mixture
templates with wild type and mutant of H. pylori were shown
in Figure 5. These data demonstrated that HMGS assay could
successfully detect and differentiate mixed infection with wild
type and mutant resistant genes of H. pylori isolates. We
perform additional test to further explore the possibility to
detect the relative contribution of wild type strain and resistant
mutant in mixed infections. DNA templates from CLA-resistant
mutant clinical isolate (23S rRNA_G) and wild type isolate
(23S rRNA_A) were prepared and amplified using following
ratio: 1:8, 1:4, 1:2,1:1, 2:1, 4:1, and 8:1 per reaction in the
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FIGURE 3 | The specificity of the HMGS assay. (A) The standard H. pylori strain (ATCC43504) was used as positive control. (B) C. jejuni, (C) E. coli,
(D) P. aeruginosa, (E) A. baumannii, (F) S. maltophilia, (G) K. pneumoniae, (H) control mix, (I) control mix and H. pylori, and (J) ddH2O were used as controls. 16S
rRNA had a specific peak at 146 bp and ureC had a specific peak at 137 bp for standard H. pylori strain. No specific peak was found in all negative controls. The
peaks in (B) to (H) and (J) around 60 bp were primer dimers, excluded according to the standards provided by the manufacturer.
HMGS assay. The relative magnitude of signals from the wild
type and mutant clinical strains corresponded to the ratio
of the mixed template. A near-identity (R2 = 0.987) linear
correlation between the peak areas and the template ratios has
been found. These results showed that wild type and mutant
isolates could be accurately quantify by HMGS assay at relatively
broad range of proportions of the mixed infection strains
(Figure 6).
Optimization of HMGS Conditions
Allowed for Efficiently Detecting of
H. pylori Directly in Gastric Biopsy
Specimens
Wild type and mutant resistant gene readouts of HMGS
assay in biopsy specimens were completely consistent with
their corresponding isolated strains. The peaks of gyrA_C
were simultaneously showed in the wild type gastric biopsy
specimen as well as in its corresponding LEV-susceptible isolates
(Figures 7A,B), and the peaks of gyrA_A/G were showed in
the mutant gastric biopsy specimens and its corresponding
LEV-resistant isolates (Figures 7C,D). Meanwhile, all H. pylori
specific peaks and human internal control gene beta-globin
were detected in two infected biopsy specimens (Figures 7A,C),
while only beta-globin was detected in uninfected biopsy
specimens (Figure 7E). Thus, these results showed an
excellent concordance between gastric biopsy specimens
and corresponding isolated strains, documenting that HMGS
assay could efficiently diagnose H. pylori infection and analyze
the virulence and drug resistance in gastric biopsy specimens
directly.
DISCUSSION
Helicobacter pylori is an important pathogen causing major
gastroduodenal disease for which rapid non-culture based
identification assays are needed (Graham, 1998). Virulence
factors contribute to the development of severe complications
in H. pylori infections and become predictors for risk of gastric
atrophy, intestinal metaplasia and other severe clinical outcomes
(Shiota et al., 2013). The severity of clinical manifestations is
associated with bacterial load (Kusters et al., 2006). Meanwhile,
the growing H. pylori drug resistance in Asia countries severely
influences the efficacy of eradication treatment, which required
drug resistance analysis before treatment (Katelaris, 2009;
Cammarota et al., 2012; Alfizah et al., 2014; Smith et al., 2014).
Therefore, it is important to analyze the virulence, bacterial load
and resistance profiles during the identification of H. pylori.
The traditional methods such as histology, culture, RUT, UBT
as well as serology are available for the detection of H. pylori,
and each method has its usefulness and limitations in different
clinical situations (Hirschl and Makristathis, 2007; Khalifehgholi
et al., 2013; Wang et al., 2015). The published guidance proposed
molecular methods, like PCR sequencing, real-time (RT-PCR)
PCR, and dual-priming oligonucleotide (DPO-PCR) should be
introduced as alternatives for conventional H. pylori detection
(Lehours et al., 2011; Malfertheiner et al., 2012) due to their high
sensitivity and accuracy compared with conventional methods.
However, these molecular methods are relatively expensive and
could not detect multiple genes at a time (Lee et al., 2014; Wang
et al., 2015). At present, there were no existing molecular methods
that could simultaneously identify and quantify H. pylori, analyze
the virulence and drug-resistance genes in single-infection and
mixed infection condition. Thus, it is urgent to explore a rapid,
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FIGURE 4 | The detection of identification, virulence and resistance genes by HMGS assay. All the target genes could be efficiently detected by HMGS,
including identification genes 16S rRNA and ureC (A−F), virulence genes cagA, dupA, luxS, vacA s1, oipA, vacA m1, and iceA2 (A), cagA, dupA, luxS, vacA s1,
oipA, and iceA1 (B), resistance genes pbp1A (A1777G) (C,D), 23S rRNA (A2143G) (C,E), gyrA(C261A/G) (C,E), and rdxA (C148T) (C,F). Note that different isolates
showed at the individual panels expressed distinct sets of identification, virulence and resistance genes, clearly identified by HMGS.
effective, and high-throughput molecular technique to diagnose,
treat, and monitor H. pylori infection. Previously, our team
has established a genetic method using 16S rRNA and ureC
for H. pylori identification and quantification (Zhou et al.,
2015). The sensitivity, specificity, positive predictive value (PPV)
and negative predictive value (NPV) were comparable to other
conventional methods, such as culture, RUT and histopathology.
In this study, we incorporated this readout into a newly developed
and optimized HMGS assay, introducing 21 newly designed
primer pairs to simultaneously detect the identification gene,
10 virulence genes, 4 drug resistance genes, quantification genes
ureC of H. pylori and internal control gene beta-globin of human
tissue to normalize the specific gene expression.
Currently, some identification methods for H. pylori such as
culture, histology, and RUT are available in clinical diagnosis but
each of these methods has some limitations (Wang et al., 2015).
The culture of gastric mucosa biopsy specimens is generally
considered as the gold standard for the identification of H. pylori.
However, culture is time consuming (Hachem et al., 1995; Cuchi
et al., 2002), and its sensitivity and specificity are restricted
with the technical difficulties, incubation environment and low
bacterial loads (Cover, 2012). Histopathology has high sensitivity
and specificity but the choice of staining methods and the
bacterial load could directly impact the histological assessment
(Christensen et al., 1992; Atherton et al., 1996; El-Zimaity
et al., 1996). Besides, RUT is also susceptible to bacteria loads
(Leodolter et al., 2001). In present study, we simultaneously
detected the identification gene, virulence and resistance genes
in six clinical isolated strains with known genetic background
(Figure 3) and the results showed an excellent concordance
with sequencing. In addition, specificity of the HMGS assay
was examined using the standard H. pylori strain (ATCC43504),
and six bacterial controls. The result showed that only standard
H. pylori strains had specific amplification signals in 16S rRNA
and ureC genes at the size of 146 and 137 bp. However, neither
H. pylori identification genes nor any of the other H. pylori-
specific amplification signals appeared in HMGS conducted on
control bacteria and negative control of ddH2O specimens. This
result demonstrated that the optimized HMGS assay was highly
specific to detect H. pylori (Figure 6). Therefore, this novel
HMGS assay is a highly rapid, specific and effective technique
compared with culture, histopathology and RUT.
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FIGURE 5 | Artificial mixture of wild type and resistant mutant isolates detected by HMGS assay. The multiplex assay was carried out with artificial mixed
wild type and resistant mutant templates for (A) pbp1A(A1777G), (B) rdxA(C148T), (C) 23SrRNA (A2143G), and (D) gyrA(C261A/G), respectively. Note that mixed
infection of wild type and mutant isolates could be accurately distinguished at a relatively broad range of proportions by HMGS assay.
Virulence factors have been reported to contribute to the
development of H. pylori related-diseases and assist to diagnose
in H. pylori infection (Proença-Modena et al., 2009). The
specific functions of the virulence-associated factors of H. pylori
is complicated, and its outcome likely affected by different
combinations of variable regions of the virulence genes and
influence of “local factors” in each studies (Shiota et al., 2013;
Yamaoka and Graham, 2014; Sgouras et al., 2015). For example,
there are variations in the functional vacA gene signal regions
(s1 and s2) and middle regions (m1 and m2 in different H. pylori
strains. Individuals infected with s1 or m1 H. pylori strains have
an increased risk compared with individuals infected with s2 or
m2 strain. Additionally, “i” region plays a role in the development
of peptic ulcer in people in Iraq and Italy (Yamaoka, 2010);
however, in a study of the patients from East and Southeast Asia,
association between the region and disease has not been detected
(Shiota et al., 2013). The immunoassay could be used to detect the
virulence factors of H. pylori. However, immunoassay is relatively
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FIGURE 6 | Correlation between the peak areas and the template
ratios of the wild type and mutant drug resistant isolates. A near-identity
(R2 = 0.987) linear correlation between the peak areas and the template
ratios showed that wild type and mutant isolates could be accurately quantify
by HMGS assay at relatively broad range of proportions of the mixed infection.
low-throughput in a single reaction. Especially, there is a window
phase between the timing of H. pylori infection and antibody
producing, which may lead to the high false negative rate (FNR)
in clinical diagnosis of H. pylori infection. By using of HMGS
assay, we here detected and analyzed 10 main virulence factors
simultaneously (Figure 4). While understanding interactions
between hosts and microbes expressing various combinations
of virulence gene is very complex and will require an amount
of data and system biology approach to analyze, we anticipate
that our rapid, accurate, and high-throughput multiple virulence
gene analysis will be a useful tool in gathering such information
for further analysis. We believe that such information will
enable us to identify the high-risk groups among carriers of
H. pylori.
The most common antibiotics for H. pylori treatment
are clarithromycin (CLA), metronidazole (MTZ), amoxicillin
(AMX), and levofloxacin (LEV) according to the guidelines
(Wolle and Malfertheiner, 2007; Gao et al., 2010; Yu et al.,
2011; Malfertheiner et al., 2012). However, the growing drug
resistance has seriously impacted the efficacy of eradication
treatment, which emphasized the need of resistance analysis
before antibiotic treatment. Conventional detection methods for
H. pylori drug resistance are culture-dependent, time-consuming,
low-throughput and could not distinguish mixed infection.
H. pylori drug resistance was related to specific gene mutations
(Gerrits et al., 2006; Tanih and Ndip, 2013). In our study, the
four wild-type genes and their main gene mutation sites of 23S
rRNA (A2143G), rdxA (C148T), gyrA (C261A/G), and pbp1A
(A1777G) were selected for HMGS to assess CLA, MTZ, LEV,
and AMX resistance. We demonstrated that the HMGS assay
performed on isolated strains was fast, effective and accurate
for simultaneous analysis for drug resistance genes (Figure 4).
Notably, the possibility of mixed infection with different drug
resistant H. pylori strains increases the difficulty of differential
diagnosis and individual eradication therapy. Here, we explored
HMGS performance in detecting mixed infection using the
artificial mixture with the wild type and mutant resistant genes,
which showed the specific and distinct amplification signals for
wild type and mutant type of H. pylori (Figure 5). Additionally,
a linear correlation between the amplification trend of wild
and mutant strains were analyzed (R2 = 0.987), indicating that
HMGS had accurately established the ratio in a board range of
mixture proportions between drug resistant mutant isolate and
the wild type H. pylori (Figure 6). Therefore, mixed infection
with wild and mutant isolates could be detected and quantified
by HMGS assay and predominant bacteria could be distinguished
in mixed infections. We anticipated that border use of HMGS
assay would improve the clinical accurate diagnosis, treatment
and monitoring.
The severity of the clinical manifestations of the H. pylori
infection was also associated with bacterial load (Kusters et al.,
2006). The most regular method used for H. pylori quantification
is RT-PCR. However, the selection of probes could easily
influence the sensitivity and reproducibility of the result (He
et al., 2002; Mikula et al., 2003). Moreover, RT-PCR could
not amplify the target and internal control genes in the same
reaction. Here, we selected the ureC as the quantification genes
for its single copy. Meanwhile, beta-globin gene was introduced
as internal control of human tissue that could normalize the
expression of specific genes of H. pylori. Therefore, HMGS
had a good prospect for the clinical diagnosis and treatment
monitoring of H. pylori.
After optimizing HMGS assay in detecting H. pylori, as well
as analyze the virulence and drug-resistance genes in isolated
strains, we further explored the clinical utility of the HMGS
assay for H. pylori diagnosis with 3 gastric biopsy specimens.
Our results showed the readouts of HMGS assay performed on
biopsy specimens were completely in agreement with the results
of clinical diagnosis. Only human internal control beta-globin
appeared in uninfected biopsy specimen (Figure 7E), while both
beta-globin and the specific peaks of H. pylori appeared in the
infected biopsy specimens (Figures 7A,C). Besides, the specific
peaks in biopsy specimens were completely consistent with that
in their corresponding isolated strains which had been confirmed
by sequencing (Figures 4A–D). Considering the limitations of
conventional detection methods for H. pylori, HMGS assay may
efficiently skip the culture step, shorten the detection time and
decrease the FNR. Based on these advantages, HMGS assay would
identifyH. pylori and detect virulence and drug resistance directly
using biopsy specimens.
CONCLUSION
In conclusion, we explored and optimized HMGS assay in
detecting and analyzing a set of genes for H. pylori identification,
quantification, virulence, and drug resistance in both isolated
strains and biopsy specimens. Also, HMGS assay could detect
mixed infections and differentiate the predominant bacteria in
artificial mixed infection strains. While present study has focused
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FIGURE 7 | Detection of antrum biopsy specimens and corresponding strains by HMGS assay. The expected amplification peaks appeared in the wild type
gyrA_C biopsy specimen (A) and its corresponding LEV-susceptible isolated strain (B). The expected amplification peaks appeared in the mutant gyrA_A/G biopsy
specimen (C) and its corresponding LEV-resistant isolated strain (D). Only beta-globin peak appeared in uninfected biopsy specimen (E).
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on technological details and demonstration of possible clinical
applications of HMGS, we believe that broad validation of its
full potential will result from future studies conducted in a
lager cohort of patients, possibly, at multiple study centers.
We anticipate that HMGS will improve the clinical diagnosis,
treatment and monitoring of H. pylori infection.
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